Generic Trileptal is currently manufactured by four companies. It is available in four strengths -- 150 mg, 300 mg, 600 mg, and 300 mg per 5 mL oral suspension.
Trileptal® (oxcarbazepine) is a prescription medication that is used to treat epilepsy. Specifically, Trileptal is approved to treat certain types of seizures (partial seizures or focal seizures) in people with epilepsy.
Trileptal is manufactured by Novartis Pharmaceuticals. However, this epilepsy medication has come off patent and is available as a generic.
Generic Trileptal is available in the following strengths:
- Oxcarbazepine 150 mg
- Oxcarbazepine 300 mg
- Oxcarbazepine 600 mg
- Oxcarbazepine 300 mg per 5 mL oral suspension.
Generic Trileptal is made by the following companies:
- Glenmark Pharmaceuticals
- Roxane Laboratories
- Ranbaxy Laboratories
- Sun Pharmaceutical Industries.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic oxcarbazepine versions currently available have an "AB" rating, meaning they should be equivalent to Trileptal.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with allergies or sensitivities.
It should also be noted that many healthcare providers believe that special care should be taken when switching a patient from a brand-name seizure medication to a generic one. For this reason, you may want to check with your healthcare provider before switching to a generic version of Trileptal (or even before switching between different generic versions of Trileptal).